PetMed Express Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 40,000 shares of PetMed Express stock in a transaction dated Monday, November 14th. The stock was sold at an average price of $21.63, for a total value of $865,200.00. Following the sale, the chief executive officer now directly owns 590,000 shares of the company’s stock, valued at approximately $12,761,700. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Menderes Akdag also recently made the following trade(s):

  • On Monday, October 10th, Menderes Akdag sold 10,000 shares of PetMed Express stock. The stock was sold at an average price of $21.00, for a total value of $210,000.00.
  • On Thursday, September 22nd, Menderes Akdag sold 10,000 shares of PetMed Express stock. The shares were sold at an average price of $20.75, for a total value of $207,500.00.

PetMed Express Inc. (NASDAQ:PETS) opened at 21.77 on Thursday. The stock has a market cap of $440.91 million, a price-to-earnings ratio of 20.35 and a beta of 1.11. PetMed Express Inc. has a 1-year low of $15.73 and a 1-year high of $22.23. The firm’s 50 day moving average price is $20.35 and its 200-day moving average price is $19.73.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, October 24th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by $0.02. PetMed Express had a return on equity of 25.77% and a net margin of 9.10%. The company had revenue of $60.80 million for the quarter, compared to analysts’ expectations of $58.47 million. During the same period in the prior year, the company posted $0.22 EPS. The firm’s revenue was up 7.2% compared to the same quarter last year. On average, equities analysts anticipate that PetMed Express Inc. will post $1.09 earnings per share for the current year.

Insider Buying and Selling by Quarter for PetMed Express (NASDAQ:PETS)

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 18th. Stockholders of record on Monday, November 7th will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 3.49%. The ex-dividend date is Thursday, November 3rd. PetMed Express’s dividend payout ratio is currently 71.03%.

Several hedge funds have recently bought and sold shares of PETS. JPMorgan Chase & Co. raised its stake in PetMed Express by 43.6% in the first quarter. JPMorgan Chase & Co. now owns 45,047 shares of the company’s stock worth $807,000 after buying an additional 13,670 shares in the last quarter. Prudential Financial Inc. raised its stake in PetMed Express by 3.4% in the first quarter. Prudential Financial Inc. now owns 48,464 shares of the company’s stock worth $868,000 after buying an additional 1,600 shares in the last quarter. First Midwest Bank Trust Division raised its stake in PetMed Express by 46.0% in the second quarter. First Midwest Bank Trust Division now owns 41,432 shares of the company’s stock worth $777,000 after buying an additional 13,058 shares in the last quarter. Hancock Holding Co. raised its stake in PetMed Express by 2.7% in the second quarter. Hancock Holding Co. now owns 95,496 shares of the company’s stock worth $1,791,000 after buying an additional 2,551 shares in the last quarter. Finally, Cardinal Capital Management raised its stake in PetMed Express by 5.4% in the second quarter. Cardinal Capital Management now owns 41,593 shares of the company’s stock worth $780,000 after buying an additional 2,145 shares in the last quarter. 74.53% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts have weighed in on the company. Zacks Investment Research upgraded PetMed Express from a “hold” rating to a “buy” rating and set a $23.00 price objective for the company in a research note on Wednesday, July 27th. Credit Suisse Group AG reiterated a “sell” rating and set a $13.00 price objective on shares of PetMed Express in a research note on Tuesday, August 16th.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

5 Day Chart for NASDAQ:PETS

Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.